Rezny Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Rezny Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-424	Closed	-$29K	–	17
2015 Q4	$29K	Hold	424	–	–	0.03%	19
2015 Q3	$25K	Buy	424 +24	+6%	+$1.52K	0.03%	24
2015 Q2	$26K	Buy	+400	New	+$26.4K	0.02%	24

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rezny Wealth Management's BMY Position: Q1 2016 in Review

Rezny Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 424 shares — an estimated $29K sold.

Rezny Wealth Management first reported a position in BMY in Q2 2015 and held it in 3 quarters. The position peaked at $29K in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Rezny Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
Rezny Wealth Management sold 424 Bristol-Myers Squibb shares in Q1 2016, an estimated $29K.
Rezny Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 3 quarters.
Rezny Wealth Management's Bristol-Myers Squibb position peaked at $29K in Q4 2015.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Rezny Wealth Management's 13F filing for Q1 2016, filed 10 May 2016.